RNF113B is a member of the ring finger protein family of E3 ubiquitin ligases, which are characterized by the presence of a zinc-finger domain that binds two zinc ions. The defining feature of RNF proteins is their role in mediating the transfer of ubiquitin to specific substrate proteins, a process that typically tags these substrates for proteasomal degradation but can also alter their activity, location, or interactions. The ubiquitination process is crucial for numerous cellular processes, including cell cycle regulation, DNA repair, and signal transduction.
The RNF113B gene encodes the RNF113B protein, which exhibits a distinctive pattern of expression and biological function. As an E3 ubiquitin ligase, RNF113B is involved in the post-translational modification of proteins through the ubiquitin-proteasome system. This system maintains cellular homeostasis by controlling the degradation of misfolded, damaged, or unnecessary proteins.The specific substrates and molecular mechanisms of action for RNF113B are not as well characterized as those of some other members of the RNF family. However, like other E3 ligases, RNF113B is believed to participate in the intricate regulation of cellular processes through its enzymatic activity. The ubiquitination of proteins by RNF113B could impact various cellular pathways, such as the stress response, DNA damage repair, or transcriptional regulation, by affecting the stability and function of key regulatory proteins.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that could impact the degradation of ubiquitinated proteins. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Another proteasome inhibitor, used in cancer therapy, might influence RNF113B-related pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
A PI3K inhibitor, can influence various signaling pathways, potentially affecting RNF113B. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, which might indirectly affect proteins involved in cell growth and survival. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
An HDAC inhibitor, which could affect gene expression, potentially influencing RNF113B. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially altering gene expression profiles. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An inhibitor of MEK, which could affect signaling pathways relevant to RNF113B function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, potentially influencing pathways associated with RNF113B. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A PI3K inhibitor, similar to LY294002, could affect signaling pathways impacting RNF113B. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Disrupts the MDM2-p53 interaction, potentially influencing pathways associated with RNF113B. |